216 related articles for article (PubMed ID: 17222360)
1. [Expression, loss of heterozygosity, and methylation of GNAT1 gene in nasopharyngeal carcinoma].
Yi HM; Ren CP; Peng D; Zhou L; Li H; Yao KT
Ai Zheng; 2007 Jan; 26(1):9-14. PubMed ID: 17222360
[TBL] [Abstract][Full Text] [Related]
2. [Identification of down-regulated expressed sequence tag at chromosome 3p21 in nasopharyngeal carcinoma].
He XS; Chen ZC; Tian F; Xiao ZQ; He ZM; Guan YJ; Li F; He CM; Yuan JH
Ai Zheng; 2003 Jan; 22(1):1-5. PubMed ID: 12561426
[TBL] [Abstract][Full Text] [Related]
3. Expression of RASSF1A gene in nasopharyngeal carcinoma.
Peng H; Zhao T; Yao KT
Di Yi Jun Yi Da Xue Xue Bao; 2003 Jul; 23(7):673-6. PubMed ID: 12865217
[TBL] [Abstract][Full Text] [Related]
4. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic and genetic alterations of the EDNRB gene in nasopharyngeal carcinoma.
Zhou L; Feng X; Shan W; Zhou W; Liu W; Wang L; Zhu B; Yi H; Yao K; Ren C
Oncology; 2007; 72(5-6):357-63. PubMed ID: 18187958
[TBL] [Abstract][Full Text] [Related]
6. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
Kao RH; Huang LC; Hsu YH
Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker.
Sun D; Zhang Z; Van do N; Huang G; Ernberg I; Hu L
Oral Oncol; 2007 Jan; 43(1):82-7. PubMed ID: 16807071
[TBL] [Abstract][Full Text] [Related]
8. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation.
Cheung HW; Ching YP; Nicholls JM; Ling MT; Wong YC; Hui N; Cheung A; Tsao SW; Wang Q; Yeun PW; Lo KW; Jin DY; Wang X
Mol Carcinog; 2005 Aug; 43(4):237-45. PubMed ID: 15937956
[TBL] [Abstract][Full Text] [Related]
10. [Mutation and expression of SEMA3B and SEMA3F gene in nasopharyngeal carcinoma].
Liu XQ; Sun M; Chen HK; Li JX; Pan ZG; Long QX; Wang XZ; Zeng YX
Ai Zheng; 2003 Jan; 22(1):16-20. PubMed ID: 12561429
[TBL] [Abstract][Full Text] [Related]
11. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma.
Kondo Y; Kanai Y; Sakamoto M; Mizokami M; Ueda R; Hirohashi S
Hepatology; 2000 Nov; 32(5):970-9. PubMed ID: 11050047
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
[TBL] [Abstract][Full Text] [Related]
13. [Differential expression of 63 novel genes located on chromosome 3p21-22 in nasopharyngeal carcinoma].
Peng H; Zhao T; Yao KT
Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):942-6, 950. PubMed ID: 16109545
[TBL] [Abstract][Full Text] [Related]
14. [Detection of KIAA1173 gene expression in nasopharyngeal carcinoma tissues and cell lines on tissue microarray].
Zhang SQ; Peng H; Song LY; Li XM; Jiang HY; Yao KT; Zhao T
Ai Zheng; 2005 Nov; 24(11):1322-6. PubMed ID: 16552956
[TBL] [Abstract][Full Text] [Related]
15. A cDNA located on chromosome 7q32 shows loss of expression in epithelial cell line of nasopharyngeal carcinoma.
Jiang N; Zhan F; Tan G; Deng L; Zhou M; Cao L; Qiu Y; Xie Y; Li G
Chin Med J (Engl); 2000 Jul; 113(7):650-3. PubMed ID: 11776040
[TBL] [Abstract][Full Text] [Related]
16. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.
Lo KW; Kwong J; Hui AB; Chan SY; To KF; Chan AS; Chow LS; Teo PM; Johnson PJ; Huang DP
Cancer Res; 2001 May; 61(10):3877-81. PubMed ID: 11358799
[TBL] [Abstract][Full Text] [Related]
17. High frequency loss of heterozygosity on the long arms of chromosomes 13 and 14 in nasopharyngeal carcinoma in Southern China.
Shao J; Li Y; Wu Q; Liang X; Yu X; Huang L; Hou J; Huang X; Ernberg I; Hu LF; Zeng Y
Chin Med J (Engl); 2002 Apr; 115(4):571-5. PubMed ID: 12133301
[TBL] [Abstract][Full Text] [Related]
18. CDX1 expression is reduced in colorectal carcinoma and is associated with promoter hypermethylation.
Pilozzi E; Onelli MR; Ziparo V; Mercantini P; Ruco L
J Pathol; 2004 Nov; 204(3):289-95. PubMed ID: 15378566
[TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation along with LOH, but not mutation, contributes to inactivation of DLC-1 in nasopharyngeal carcinoma.
Feng X; Ren C; Zhou W; Liu W; Zeng L; Li G; Wang L; Li M; Zhu B; Yao K; Jiang X
Mol Carcinog; 2014 Nov; 53(11):858-70. PubMed ID: 23908159
[TBL] [Abstract][Full Text] [Related]
20. [Differentially expressed transcription factor-related genes in nasopharyngeal carcinoma and nasopharyngeal tissues].
Wang S; Lu LC; Fang WY; Yao KT
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):146-9. PubMed ID: 17355921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
